Coronavirus Disease 2019 (COVID-19) Response Team, Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Coronavirus Disease 2019 (COVID-19) Response Team, Laboratory Leadership Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Clin Infect Dis. 2021 Jun 1;72(11):e761-e767. doi: 10.1093/cid/ciaa1469.
Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has principally been performed through the use of real-time reverse-transcription polymerase chain reaction testing. Results of such tests can be reported as cycle threshold (Ct) values, which may provide semi-quantitative or indirect measurements of viral load. Previous reports have examined temporal trends in Ct values over the course of a SARS-CoV-2 infection.
Using testing data collected during a prospective household transmission investigation of outpatient and mild coronavirus disease 2019 cases, we examined the relationships between Ct values of the viral RNA N1 target and demographic, clinical, and epidemiological characteristics collected through participant interviews and daily symptom diaries.
We found that Ct values are lowest (corresponding to a higher viral RNA concentration) soon after symptom onset and are significantly correlated with the time elapsed since onset (P < .001); within 7 days after symptom onset, the median Ct value was 26.5, compared with a median Ct value of 35.0 occurring 21 days after onset. Ct values were significantly lower among participants under 18 years of age (P = .01) and those reporting upper respiratory symptoms at the time of sample collection (P = .001), and were higher among participants reporting no symptoms (P = .05).
These results emphasize the importance of early testing for SARS-CoV-2 among individuals with symptoms of respiratory illness, and allow cases to be identified and isolated when their viral shedding may be highest.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的检测主要通过实时逆转录聚合酶链反应检测来进行。此类检测的结果可以报告为循环阈值(Ct)值,Ct 值可提供病毒载量的半定量或间接测量。先前的报告已经研究了 SARS-CoV-2 感染过程中 Ct 值的时间趋势。
我们使用在门诊和轻症 2019 年冠状病毒病(coronavirus disease 2019,COVID-19)病例的前瞻性家庭传播调查中收集的检测数据,研究了病毒 RNA N1 靶标 Ct 值与通过参与者访谈和每日症状日记收集的人口统计学、临床和流行病学特征之间的关系。
我们发现,在症状出现后不久,Ct 值最低(对应于更高的病毒 RNA 浓度),并且与发病后时间的流逝呈显著相关(P<0.001);在症状出现后 7 天内,中位 Ct 值为 26.5,而在发病后 21 天,中位 Ct 值为 35.0。在 18 岁以下的参与者(P=0.01)和在样本采集时报告上呼吸道症状的参与者(P=0.001)中,Ct 值明显较低,而在报告无症状的参与者中(P=0.05),Ct 值较高。
这些结果强调了对有呼吸道疾病症状的个体进行早期 SARS-CoV-2 检测的重要性,并且可以在病毒脱落可能最高时识别和隔离病例。